Imis Dogan1,2,3, Simon B Eickhoff2,4, Jörg B Schulz1,3, N Jon Shah1,2,3, Angela R Laird5, Peter T Fox5, Kathrin Reetz1,2,3. 1. Department of Neurology, RWTH Aachen University, Aachen. 2. Institute of Neuroscience and Medicine, Research Center Jülich GmbH, Jülich. 3. Translational Brain Medicine, Jülich Aachen Research Alliance, Jülich. 4. Institute of Clinical Neuroscience and Medical Psychology, Heinrich Heine University, Düsseldorf , Germany. 5. Research Imaging Center, University of Texas Health Science Center San Antonio, San Antonio, Tex. , USA.
Abstract
BACKGROUND: The neuropathological hallmark of Huntington's disease (HD) is progressive striatal loss starting several years prior to clinical onset. In the past decade, whole-brain magnetic resonance imaging (MRI) studies have provided accumulating evidence for widely distributed cortical and subcortical atrophy in the early course of the disease. OBJECTIVE: In order to synthesize current morphometric MRI findings and to investigate the impact of clinical and genetic features on structural changes, we performed a coordinate-based meta-analysis of voxel-based morphometry (VBM) studies in HD. METHODS: Twenty HD samples derived from 17 studies were integrated in the analysis comparing a total of 685 HD mutation carriers [345 presymptomatic (pre-HD) and 340 symptomatic (symp-HD) subjects] and 507 controls. Convergent findings across studies were delineated using the anatomical likelihood estimation approach. Effects of genetic and clinical parameters on the likelihood of observing VBM findings were calculated by means of correlation analyses. RESULTS: Pre-HD studies featured convergent evidence for neurodegeneration in the basal ganglia, amygdala, thalamus, insula and occipital regions. In symp-HD, cerebral atrophy was more pronounced and spread to cortical regions (i.e., inferior frontal, premotor, sensorimotor, midcingulate, frontoparietal and temporoparietal cortices). Higher cytosine-adenosine-guanosine repeats were associated with striatal degeneration, while parameters of disease progression and motor impairment additionally correlated with cortical atrophy, especially in sensorimotor areas. CONCLUSION: This first quantitative meta-analysis in HD demonstrates the extent of striatal atrophy and further consistent extrastriatal degeneration before clinical conversion. Sensorimotor areas seem to be core regions affected in symp-HD and, along with widespread cortical atrophy, may account for the clinical heterogeneity in HD.
BACKGROUND: The neuropathological hallmark of Huntington's disease (HD) is progressive striatal loss starting several years prior to clinical onset. In the past decade, whole-brain magnetic resonance imaging (MRI) studies have provided accumulating evidence for widely distributed cortical and subcortical atrophy in the early course of the disease. OBJECTIVE: In order to synthesize current morphometric MRI findings and to investigate the impact of clinical and genetic features on structural changes, we performed a coordinate-based meta-analysis of voxel-based morphometry (VBM) studies in HD. METHODS: Twenty HD samples derived from 17 studies were integrated in the analysis comparing a total of 685 HD mutation carriers [345 presymptomatic (pre-HD) and 340 symptomatic (symp-HD) subjects] and 507 controls. Convergent findings across studies were delineated using the anatomical likelihood estimation approach. Effects of genetic and clinical parameters on the likelihood of observing VBM findings were calculated by means of correlation analyses. RESULTS: Pre-HD studies featured convergent evidence for neurodegeneration in the basal ganglia, amygdala, thalamus, insula and occipital regions. In symp-HD, cerebral atrophy was more pronounced and spread to cortical regions (i.e., inferior frontal, premotor, sensorimotor, midcingulate, frontoparietal and temporoparietal cortices). Higher cytosine-adenosine-guanosine repeats were associated with striatal degeneration, while parameters of disease progression and motor impairment additionally correlated with cortical atrophy, especially in sensorimotor areas. CONCLUSION: This first quantitative meta-analysis in HD demonstrates the extent of striatal atrophy and further consistent extrastriatal degeneration before clinical conversion. Sensorimotor areas seem to be core regions affected in symp-HD and, along with widespread cortical atrophy, may account for the clinical heterogeneity in HD.
Authors: Peter E Turkeltaub; Simon B Eickhoff; Angela R Laird; Mick Fox; Martin Wiener; Peter Fox Journal: Hum Brain Mapp Date: 2011-02-08 Impact factor: 5.038
Authors: Simon B Eickhoff; Angela R Laird; Christian Grefkes; Ling E Wang; Karl Zilles; Peter T Fox Journal: Hum Brain Mapp Date: 2009-09 Impact factor: 5.038
Authors: Hosung Kim; Ji-Hoon Kim; Katherine L Possin; Joseph Winer; Michael D Geschwind; Duan Xu; Christopher P Hess Journal: Brain Imaging Behav Date: 2017-10 Impact factor: 3.978
Authors: Robert Christian Wolf; Philipp Arthur Thomann; Fabio Sambataro; Nadine Donata Wolf; Nenad Vasic; G Bernhard Landwehrmeyer; Sigurd Dietrich Süßmuth; Michael Orth Journal: J Neurol Date: 2015-01-28 Impact factor: 4.849
Authors: Cornelius J Werner; Imis Dogan; Christian Saß; Shahram Mirzazade; Johannes Schiefer; N Jon Shah; Jörg B Schulz; Kathrin Reetz Journal: Hum Brain Mapp Date: 2013-08-24 Impact factor: 5.038
Authors: Lora Minkova; Simon B Eickhoff; Ahmed Abdulkadir; Christoph P Kaller; Jessica Peter; Elisa Scheller; Jacob Lahr; Raymund A Roos; Alexandra Durr; Blair R Leavitt; Sarah J Tabrizi; Stefan Klöppel Journal: Hum Brain Mapp Date: 2015-10-10 Impact factor: 5.038
Authors: Philipp Honrath; Imis Dogan; Olga Wudarczyk; Katharina S Görlich; Mikhail Votinov; Cornelius J Werner; Beate Schumann; Rena T Overbeck; Jörg B Schulz; Bernhard G Landwehrmeyer; Raquel E Gur; Ute Habel; Kathrin Reetz Journal: J Neurol Date: 2018-08-27 Impact factor: 4.849
Authors: Flor A Espinoza; Jessica A Turner; Victor M Vergara; Robyn L Miller; Eva Mennigen; Jingyu Liu; Maria B Misiura; Jennifer Ciarochi; Hans J Johnson; Jeffrey D Long; Henry J Bockholt; Vincent A Magnotta; Jane S Paulsen; Vince D Calhoun Journal: Brain Connect Date: 2018-03-08
Authors: Sarah Gregory; Jeffrey D Long; Stefan Klöppel; Adeel Razi; Elisa Scheller; Lora Minkova; Eileanoir B Johnson; Alexandra Durr; Raymund A C Roos; Blair R Leavitt; James A Mills; Julie C Stout; Rachael I Scahill; Sarah J Tabrizi; Geraint Rees Journal: Brain Date: 2018-07-01 Impact factor: 13.501
Authors: Michal Mielcarek; Marta Toczek; Cleo J L M Smeets; Sophie A Franklin; Marie K Bondulich; Nelly Jolinon; Thomas Muller; Mhoriam Ahmed; James R T Dick; Izabela Piotrowska; Linda Greensmith; Ryszard T Smolenski; Gillian P Bates Journal: PLoS Genet Date: 2015-03-06 Impact factor: 5.917